Curocell (XKRX:372320) Other Gross PPE : ₩3,548.60 Mil (As of Jun. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Curocell Other Gross PPE?

Curocell's Other Gross PPE for the quarter that ended in Jun. 2023 was ₩3,548.60 Mil.

Curocell's quarterly Other Gross PPE increased from Jun. 2022 (₩0.00 Mil) to Dec. 2022 (₩3,690.58 Mil) but then declined from Dec. 2022 (₩3,690.58 Mil) to Jun. 2023 (₩3,548.60 Mil).

Curocell's annual Other Gross PPE increased from Dec. 2021 (₩3,514.01 Mil) to Dec. 2022 (₩3,690.58 Mil) and increased from Dec. 2022 (₩3,690.58 Mil) to Dec. 2023 (₩3,732.82 Mil).

Curocell Other Gross PPE Historical Data

The historical data trend for Curocell's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Other Gross PPE Chart

Curocell Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Other Gross PPE

3,375.62

3,475.03

3,514.01

3,690.58

3,732.82

Curocell Semi-Annual Data
	Jun22	Dec22	Jun23	Dec23
Other Gross PPE	-	3,690.58	3,548.60	3,732.82

Curocell Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Curocell (XKRX:372320) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

N/A

Address

11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002

Website

https://www.curocellbtx.com

Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines